Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.

@article{Espinosa2015PegylatedI,
  title={Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.},
  author={Mario Isaac Menes Espinosa and Jes{\'u}s Hern{\'a}ndez and Mar{\'i}a Dolores Llamb{\'e}s Arenas and Fernando Carnicer and Carlos Caramelo and Fabrizio Fabrizi},
  journal={Kidney & blood pressure research},
  year={2015},
  volume={40 3},
  pages={
          258-65
        }
}
BACKGROUND/AIMS Hepatitis C virus infection remains prevalent among patients undergoing long-term haemodialysis and has a detrimental impact on survival in this population. Antiviral therapy for chronic hepatitis C in haemodialysis patients is still a challenge to clinicians. The aim of the current study is to evaluate the efficacy and safety of therapy with pegylated interferon, alone or combined with ribavirin, for chronic hepatitis C among patients undergoing long-term hemodialysis… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?

  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2013